Within the CCR are five programmatic initiatives designed to accelerate the pace of discovery to help future patients: The Center for Molecular Therapeutics (CMT), The Translational Research Laboratory (TRL), The Circulating Tumor Cell Initiative, The Center for Computational Discovery, and the Molecular Profiling Laboratory.
The Center for Molecular Therapeutics is actively investigating better ways to match individual cancer patients with particular targeted drug therapies in order to maximize the likelihood of a clinical response.
The Translational Research Laboratory is dedicated to fostering personalized cancer patient care, through development and implementation of innovative tumor genotyping technologies and collaborative clinical and translational research studies.
The Circulating Tumor Cell Initiative's goal is to transform the CTC-Chip into a robust technology that will allow detailed studies across multiple different types of cancer.
The Center for Computational Discovery (CCD) uses computational, bioinformatic, and statistical approaches to analyze complex biological datasets for basic discovery, translational, and clinical research.
The Molecular Profiling Laboratory (MPL) provide technological support to Cancer Center investigators.